Commonwealth Equity Services
ARIA

Commonwealth Equity Services’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Commonwealth Equity Services’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-23,354
Closed -$291K – 2518
2016
Q4 		$291K Sell
23,354
-75
-0.3% -$903 ﹤0.01% 1790
2016
Q3 		$321K Hold
23,429
– – ﹤0.01% 1659
2016
Q2 		$173K Sell
23,429
-5,303
-18% -$39.8K ﹤0.01% 2007
2016
Q1 		$184K Hold
28,732
– – ﹤0.01% 1939
2015
Q4 		$180K Sell
28,732
-4,850
-14% -$31.8K ﹤0.01% 1905
2015
Q3 		$196K Buy
33,582
+3,203
+11% +$24.7K ﹤0.01% 1845
2015
Q2 		$251K Sell
30,379
-6,850
-18% -$60.6K ﹤0.01% 1764
2015
Q1 		$307K Buy
37,229
+13,910
+60% +$103K ﹤0.01% 1621
2014
Q4 		$160K Sell
23,319
-13,026
-36% -$81.5K ﹤0.01% 1904
2014
Q3 		$196K Sell
36,345
-32,950
-48% -$192K ﹤0.01% 1844
2014
Q2 		$441K Buy
69,295
+19,803
+40% +$136K 0.01% 1316
2014
Q1 		$399K Buy
49,492
+31,262
+171% +$243K 0.01% 1310
2013
Q4 		$124K Buy
18,230
+3,560
+24% +$19.2K ﹤0.01% 1796
2013
Q3 		$270K Sell
14,670
-41
-0.3% -$796 ﹤0.01% 1437
2013
Q2 		$257K Buy
+14,711
New +$261K ﹤0.01% 1405

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Commonwealth Equity Services's ARIA Position: Q1 2017 in Review

Commonwealth Equity Services sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 23,354 shares — an estimated $291K sold.

Commonwealth Equity Services first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $441K in Q2 2014. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Commonwealth Equity Services reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Commonwealth Equity Services sold 23,354 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $291K.
  • Commonwealth Equity Services first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • Commonwealth Equity Services's Ariad Pharmaceuticals Inc position peaked at $441K in Q2 2014.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Commonwealth Equity Services's 13F filing for Q1 2017, filed 15 May 2017.